Search
for
Sort by
Research 181–210 of 1000+
- 805 Topical thyroid hormones promote hair follicle and epithelial hair follicle stem cell growth in intact human scalp skin ex vivo
- A Botanical Compound for the Treatment of Alopecia Areata and Chemotherapy-Induced Alopecia
- Mesenchymal Stromal Cell-Conditioned Medium for Skin Diseases: A Systematic Review
- Evaluating hair growth promoting effects of candidate substance: A review of research methods
- Hair growth control by innate immunocytes: Perifollicular macrophages revisited
- Hair Regeneration Effects of Lespedeza bicolor Extract In Vivo and In Vitro
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- A Practitioner's Guide to Hair Loss Part 1—History, Biology, Genetics, Prevention, Conventional Treatments, and Herbals
- Extracellular Vesicles Including Exosomes for Hair Follicle Regeneration
- Exploring novel management options for alopecia areata
- Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
- Teriflunomide in multiple sclerosis: an update
- Baricitinib for the Treatment of Alopecia Areata
- JAK inhibition decreases the autoimmune burden in Down syndrome
- La FDA aprueba Litfulo® (ritlecitinib) para el tratamiento de la alopecia areata grave en adolescentes y adultos
- Lower Urinary Tract Symptoms: What’s New in Medical Treatment?
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Industry updates from the field of stem cell research and regenerative medicine in June 2019
- N‑K GM SERIES: COMPLETE HAIR MEDICINES COLLECTION — From L‑Series Longevity to Dedicated Hair Restoration: BALDNESS-GM1, HAIR-REMOVE-GM1, and the Complete Hair Health Protocol
- Activity‐based therapeutic algorithm for folliculitis decalvans: A practical tool for effective management
- Recent trends in nanocarrier formulations of actives beyond minoxidil and 5-α reductase inhibitors in androgenetic alopecia management: A systematic review
- Abstract P5-09-21: Selective androgen receptor modulators (SARMs): Enobosarm as targeted therapy for the treatment of androgen receptor-positive breast cancer
- A comprehensive review of the medical and cosmetic applications of exosomes in dermatology
- The use of phytochemicals and other natural materials in the treatment of androgenetic alopecia
- Phase II trial of paclitaxel poliglumex (CT-2103) in pre- and post-menopausal women on hormonal replacement therapy (HRT) with non-small cell lung cancer (NSCLC).
- Phase I-II trial of weekly bicalutamide in men with high PSA and negative biopsy
- Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy